Publication:
Prevalence of human immunodeficiency virus-1 drugresistant mutations among adults on first- and second-line antiretroviral therapy in a resourcelimited health facility in Busia County, Kenya

dc.contributor.authorOlipher Makwaga, Maureen Adhiambo, David Hughes Mulama, John Muoma, Ferdinard Adungo, Humphrey Wanjiku, Asiko Ongaya, Geoffrey Mutisya Maitha, Matilu Mwau
dc.date.accessioned2026-11-20T11:29:18Z
dc.date.issued2020-12-03
dc.description.abstractIntroduction: in Kenya, about 1.5 million people are living with the Human Immunodeficiency Virus (HIV). Antiretroviral therapy aids in viral suppression. However, drug-resistance threaten the gains of the HIV infection control program. To determine the prevalence of HIV-1 drug-resistant mutations among adults on ARV therapy attending Khunyangu sub-county hospital in Busia County, Kenya, 50 blood samples were analyzed. Methods: the samples were collected from November 2019 to January 2020 and tested for HIV-1 viral load. HIV-1 drug-resistance was analyzed through the sequencing of the HIV-1 pol gene. Generated sequences were aligned using RECall (beta v3.05) software. HIV-1 drug-resistance was determined using the Stanford University HIV database. Results: females were 34 and males 16. The general prevalence of HIV-1 drug-resistance was 68%. Out of 34 participants on first-line drugs, 59.9% had mutations against these drugs and 5.9% against the second-line drugs. Out of 16 participants on secondline drugs, 43.8% had mutations against these drugs and 50% against the first-line drugs. The prevalence of mutations encoding resistance to Nucleotide reverse transcriptase inhibitors (NRTIs) were 23(46%); Non-nucleotide Reverse transcriptase inhibitors (NNRTIs), 29(58%) and protease inhibitors (PIs), 7(14%). Dual and multiclass HIV-1 drug-resistance prevalence was as follows: NRTIs + NNRTIs 16(32%); NRTIs + NNRTs + PIs 4(8%); NRTIs + PIs 1(2%). A total of 126 mutations were identified. Predominant NNRTIs mutations were K103N (15), Y181C (9), G190A (7), and H221Y (6) NRTIs, M184V (17), Y115F (5) and PIs, I54V (4). Conclusion: the study demonstrates a high prevalence of HIV-1 drug-resistance which calls for intervention for the strengthening of health programs
dc.description.sponsorshipNRF
dc.identifier.urihttps://www.panafrican-med-journal.com//content/article/37/311/full
dc.identifier.urihttps://repository.nrf.go.ke/handle/123456789/1695
dc.language.isoen
dc.relation.ispartofseriesAfrican Medical Journal. 2020;37(311). 10.11604/pamj.2020.37.311.25909
dc.titlePrevalence of human immunodeficiency virus-1 drugresistant mutations among adults on first- and second-line antiretroviral therapy in a resourcelimited health facility in Busia County, Kenya
dc.typeArticle
dspace.entity.typePublication

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
311.pdf
Size:
522.18 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: